Design and synthesis of some oxadiazolyl, thiadiazolyl, thiazolidinyl, and thiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents

Archiv der Pharmazie

Volumn 333, Issue 2-3, 2000, Pages 53-57

  Farghaly, Ahmed A ^a   Bekhit, Adnan A ^a   Park, Ji Young ^b  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b Sookmyung Women's University   (South Korea)

Author keywords

Anti inflammatory; Antimicrobial; Oxadiazolyl; Pyrazole; Thiadiazolyl; Thiazolidinyl; Thiazolyl

Indexed keywords

3 (5 BROMO 2 THIENYL) 1 PHENYL 4 (3 SUBSTITUTED 4 OXOTHIAZOLIDIN 2 YLIDENEHYDRAZONOMETHYL) 1H PYRAZOLE; 3 (5 BROMO 2 THIENYL) 1 PHENYL 4 (3 SUBSTITUTED 4 PHENYL 2,3 DIHYDROTHIAZOL 2 YLIDENE HYDRAZONOMETHYL) 1H PYRAZOLE; 3 (5 BROMO 2 THIENYL) 1 PHENYL 4 [3 ACETYL 5 (N SUBSTITUTED ACETAMIDO) 2,3 DIHYDRO 1,3,4 THIADIAZOL 2 YL] 1H PYRAZOLE; AMPICILLIN; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CLOTRIMAZOLE; PROQUAZONE; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYCLIZATION; DRUG DESIGN; DRUG SYNTHESIS; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0034037250     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4184(200002)333:2/3<53::aid-ardp53>3.3.co;2-5     Document Type: Article

References (17)

1. A. K. Gadad, B. S. Kittur, S. G. Kapsi, C. S. Mahajanshetti, S. B. Rajur, Arzneim. Forsch. 1996, 46, 1082-1085.
2. T. D. Penning, J. J. Talley, S. R. Bertenshaw, J. S. Carter, P. W. Collins, S. Docter, M. J. Graneto, L. F. Lee, J. W. Malecha, J. M. Miyashiro, R. S. Rogers, D. J. Rogier, S. S. Yu, G. D. Anderson, E. G. Burton, J. N. Cogburn, S. A. Gregory, C. M. Koboldt, W. E. Perkins, K. Seibert, A. W. Veenhuizen, Y. Y. Zhang, P.C. Isakson, J. Med. Chem. 1997, 40, 1347-1365.
3. K. Tsuji, K. Nakamura, T. Ogino, N. Konishi, T. Tojo, T. Ochi, N. Seki, M. Matsuo, Chem. Pharm. Bull. 1998, 46, 279-286.
4. S. A. Beers, E. A. Malloy, W. Wu, M. Wachter, J. Ansell, M. Singer, M. Steber, A. Barbone, T. Kirchner, D. Ritchie, D. Argentieri, Bioorg. Med. Chem. 1997, 5, 779-786.
5. P. C. Unangst, G. P. Shrum, D. T. Connor, R. D. Dyer, D. J. Schrier, J. Med. Chem. 1992, 35, 3691-3698.
6. D. H. Boschelli, D. T. Connor, D.A. Bornemeier, R. D. Dyer, J.A. Kennedy, P. J. Kuipers, G. C. Okonkwo, D. J. Schrier, C. D. Wright, J. Med. Chem. 1993, 36, 1802-1810.
7. A. M. Farghaly, I. Chaaban, M. A. Khalil, A. A. Bekhit, Arch. Pharm. 1990, 323, 311-318.
8. A. M. Farghaly, I. Chaaban, M. A. Khalil, A. A. Bekhit, Alex. J. Pharm. Sci. 1990, 4, 52-56.
9. A. M. Farghaly, I. Chaaban, M. A. Khalil, A. A. Bekhit, Arch. Pharm. 1990, 323, 833-836.
10. M. A. Khalil, R. Soliman, A. M. Farghaly, A. A. Bekhit, Arch. Pharm. 1994, 327, 27-30.
11. A. A. Bekhit, M. A. Khalil, Pharmazie 1998, 53, 539-543.
12. M. A. Khalil, Alex. J. Pharm. Sci. 1989, 3, 221-224.
13. A. M. Farghaly, A. Mohsen M. E. Omar, M. A. Khalil, M. A. Gaber, H. Abou-Shleih, Eur. J. Med. Chem. 1987, 22, 369-374.
14. M. Bernard, E. Hulley, H. Molenda, K. Stochla, U. Wrzeciono, Pharmazie 1986, 41, 560-562.
15. R. Meier, W. Schuler, P. Desaulles, Experientia 1950, 6, 469.
16. P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, R. H. Yolken, Manual of Clinical Microbiology, G. L. Woods, J. A. Washington, Antimicrobial Agents and Susceptibility Testing, 6th. ed., Am. Soc. Microbiol., Washington, DC, 1995.
17. P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, R. H. Yolken, Manual of Clinical Microbiology, G. L. Woods, J. A. Washington, Antimicrobial Agents and Susceptibility Testing, 6th. ed., Am. Soc. Microbiol., Washington, DC, 1995.